Glutathione and glutamate levels in the diaphragm of patients with chronic obstructive pulmonary disease

European Respiratory Journal

Volumn 23, Issue 4, 2004, Pages 545-551

  Engelen, M P K J ^a   Orozco Levi, M ^b   Deutz, N E P ^a   Barreiro, E ^b   Hernandez N ^b   Wouters, E F M ^a   Gea, J ^b   Schols, A M W J ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Chronic obstructive pulmonary; Diaphragm; Disease; Glutamate; Glutathione

Indexed keywords

AMINO ACID; GLUTAMIC ACID; GLUTATHIONE; MYOSIN HEAVY CHAIN;

ADULT; AGED; AMINO ACID ANALYSIS; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAPHRAGM; FORCED EXPIRATORY VOLUME; GLUTATHIONE METABOLISM; HUMAN; HUMAN TISSUE; LUNG FUNCTION; MALE; MUSCLE BIOPSY; MUSCLE METABOLISM; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUADRICEPS FEMORIS MUSCLE; STATISTICAL SIGNIFICANCE; THORACOTOMY; TISSUE DISTRIBUTION; TISSUE LEVEL; TISSUE SPECIFICITY; TISSUE TYPES;

AGED; AMINO ACIDS; BIOPSY; DIAPHRAGM; FORCED EXPIRATORY VOLUME; FUNCTIONAL RESIDUAL CAPACITY; GLUTAMIC ACID; GLUTATHIONE; HUMANS; INHALATION; MALE; MIDDLE AGED; MUSCLE FIBERS; MUSCLE FIBERS, SLOW-TWITCH; MUSCLE, SKELETAL; MYOSIN HEAVY CHAINS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STATISTICS, NONPARAMETRIC; THORACOTOMY;

EID: 1842533282     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.00022204     Document Type: Article

References (35)

1. Engelen MPKJ, Wouters EFM, Deutz NEP, Does JD, Schols AMWJ. Effects of exercise on amino acid metabolism in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 859-864.
2. Pouw EM, Schols AMWJ, Deutz NEP, Wouters EFM. Plasma and muscle amino-acid levels in relation to resting energy expenditure and inflammation in stable COPD. Am J Respir Crit Care Med 1998; 158: 797-801.
3. Engelen MPKJ, Schols AMWJ, Does JD, Deutz NEP, Wouters EFM. Altered glutamate metabolism is associated with reduced muscle glutathione levels in patients with emphysema. Am J Respir Crit Care Med 2000; 161: 98-103.
4. Engelen MPKJ, Schols AMWJ, Does JD, Gosker HR, Deutz NEP, Wouters EFM. Exercise-induced lactate increase in relation to muscle substrates in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162: 1697-1704.
5. Orozco-Levi M, Lloreta J, Minguella J, Serrano S, Broquetas JM, Gea J. Injury of the human diaphragm associated with exertion and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 1734-1739.
6. Levine S, Kaiser L, Leferovich J, Tikunov B. Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease. N Engl J Med 1997; 337: 1799-1806.
7. Whittom F, Jobin J, Simard PM, et al. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc 1998; 30: 1467-1474.
8. Satta A, Migliori GB, Spanevello A, et al. Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance. Eur Respir J 1997; 10: 2853-2860.
9. Jakobsson P, Jorfeldt L, Brundin A. Skeletal muscle metabolites and fibre types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure. Eur Respir J 1990; 3: 192-196.
10. Maltais F, Sullivan MJ, LeBlanc P, et al. Altered expression of myosin heavy chain in the vastus lateralis muscle in patients with COPD. Eur Respir J 1999; 13: 850-854.
11. Turinsky J, Long CL. Free amino acids in muscle: Effect of muscle fiber population and denervation. Am J Physiol 1990; 258: E485-E491.
12. Essen-Gustavsson B, Blomstrand E. Effect of exercise on concentrations of free amino acids in pools of type I and type II fibres in human muscle with reduced glycogen stores. Acta Physiol Scand 2002; 174: 275-281.
13. Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8: 1398-1420.
14. World Medical Association. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. Washington, DC, World Medical Association, 2002.
15. Roca J, Sanchis J, Agusti-Vidal A, et al. Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir 1986; 22: 217-224.
16. Roca J, Rodriguez-Roisin R, Cobo E, Burgos F, Perez J, Clausen JL. Single-breath carbon monoxide diffusing capacity prediction equations from a Mediterranean population. Am Rev Respir Dis 1990; 141: 1026-1032.
17. Aran X, Gea J, Guiu R, Aguar MC, Sauleda J, Broquetas JM. Comparison between three different manoeuvres for achieving maximal transdiaphragmatic pressures. Arch Bronconeumol 1992; 28: 112-115.
18. Black LF, Hyatt RE. Maximal respiratory values: Normal values and relationship to age and sex. Am Rev Respir Dis 1969; 99: 696 702.
19. Wilson SH, Cooke NT, Edwards RH, Spiro SG. Predicted normal values for maximal respiratory pressures in Caucasian adults and children. Thorax 1984; 39: 535-538.
20. Dubowitz V, Brooke MH. Muscle biopsy: A modern approach. In: Dubowitz V, Brooke MH, eds. Major Problems in Neurology. London, Saunders, 1973; pp. 74-85.
21. Poole DC, Lieber RL, Mathieu-Costello O. Myosin and actin filament lengths in diaphragms from emphysematous hamsters. J Appl Physiol 1994; 76: 1220-1225.
22. Brooke MH, Engel WK. The histographic analysis of human muscle biopsies with regard to fiber types. 1. Adult male and female. Neurology 1969; 19: 221-233.
23. Hards JM, Reid WD, Pardy RL, Pare PD. Respiratory muscle fiber morphometry. Correlation with pulmonary function and nutrition. Chest 1990; 97: 1037-1044.
24. Ramirez-Sarmiento A, Orozco-Levi M, Guell R, et al. Inspiratory muscle training in patients with chronic obstructive pulmonary disease: Structural adaptation and physiologic outcomes. Am J Respir Crit Care Med 2002; 166: 1491-1497.
25. Van Eijk HM, van der Heijden MA, van Berlo CL, Soeters PB. Fully automated liquid-chromatographic determination of amino acids. Clin Chem 1988; 34: 2510-2513.
26. Van Eijk HMH, Rooyakkers DR, Deutz NEP. Rapid routine determination of amino acids in plasma by high-performance liquid chromatography with a 2-3 microns Spherisorb ODS II column. J Chromatogr 1993; 620: 143-148.
27. Rabinovich RA, Ardite E, Troosters T, et al. Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 1114-1118.
28. Orozco-Levi M, Gea J, Lloreta JL, et al. Subcellular adaptation of the human diaphragm in chronic obstructive pulmonary disease. Eur Respir J 1999; 13: 371-378.
29. Belcastro AN, Shewchuk LD, Raj DA. Exercise-induced muscle injury: A calpain hypothesis. Mol Cell Biochem 1998; 179: 135-145.
30. Jiang TX, Reid WD, Belcastro A, Road JD. Load dependence of secondary diaphragm inflammation and injury after acute inspiratory loading. Am J Respir Crit Care Med 1998; 157: 230-236.
31. Heunks LM, Vina J, van Herwaarden CL, Folgering HT, Gimeno A, Dekhuijzen PN. Xanthine oxidase is involved in exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am J Physiol 1999; 277: R1697-R1704.
32. 2 therapy. J Appl Physiol 1996; 81: 2199-2202.
33. Engelen MPKJ, Wouters EFM, Deutz NEP, Menheere PP, Schols AMWJ. Factors contributing to alterations in skeletal muscle and plasma amino acid profiles in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 2000; 72: 1480-1487.
34. Nguyen T, Shrager J, Kaiser L, et al. Developmental myosin heavy chains in the adult human diaphragm: Coexpression patterns and effect of COPD. J Appl Physiol 2000; 88: 1446-1456.
35. Levine S, Gregory C, Nguyen T, et al. Bioenergetic adaptation of individual human diaphragmatic myofibers to severe COPD. J Appl Physiol 2002; 92: 1205-1213.